Eqis Capital Management Inc. Sells 797 Shares of NextGen Healthcare, Inc. (NASDAQ:NXGN)

Eqis Capital Management Inc. lessened its position in shares of NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) by 4.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,529 shares of the company’s stock after selling 797 shares during the period. Eqis Capital Management Inc.’s holdings in NextGen Healthcare were worth $288,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income raised its stake in NextGen Healthcare by 124.1% during the second quarter. MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income now owns 503,178 shares of the company’s stock worth $8,775,000 after buying an additional 278,607 shares during the last quarter. Texas Permanent School Fund raised its stake in NextGen Healthcare by 1.9% during the second quarter. Texas Permanent School Fund now owns 40,596 shares of the company’s stock worth $708,000 after buying an additional 776 shares during the last quarter. State Board of Administration of Florida Retirement System grew its holdings in NextGen Healthcare by 58.7% in the second quarter. State Board of Administration of Florida Retirement System now owns 144,698 shares of the company’s stock worth $2,524,000 after purchasing an additional 53,514 shares during the period. MQS Management LLC acquired a new stake in NextGen Healthcare in the second quarter worth $176,000. Finally, Seizert Capital Partners LLC grew its holdings in NextGen Healthcare by 56.7% in the second quarter. Seizert Capital Partners LLC now owns 239,344 shares of the company’s stock worth $4,174,000 after purchasing an additional 86,618 shares during the period. Institutional investors own 73.80% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on NXGN. StockNews.com upgraded shares of NextGen Healthcare from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 27th. Truist Financial began coverage on shares of NextGen Healthcare in a report on Wednesday, September 7th. They set a “hold” rating and a $20.00 price objective for the company. TheStreet upgraded shares of NextGen Healthcare from a “c” rating to a “b-” rating in a report on Wednesday, October 26th. SVB Leerink lifted their price objective on shares of NextGen Healthcare from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 26th. Finally, Piper Sandler reiterated a “neutral” rating and set a $20.00 price objective on shares of NextGen Healthcare in a report on Friday, October 21st. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.75.

NextGen Healthcare Stock Performance

NextGen Healthcare stock opened at $20.34 on Wednesday. NextGen Healthcare, Inc. has a fifty-two week low of $15.32 and a fifty-two week high of $21.99. The stock has a market cap of $1.38 billion, a PE ratio of 65.61 and a beta of 1.00. The firm’s 50-day simple moving average is $18.33 and its 200 day simple moving average is $18.01.

Insider Buying and Selling

In related news, EVP Mitchell Waters sold 9,783 shares of the business’s stock in a transaction dated Tuesday, November 8th. The shares were sold at an average price of $20.50, for a total transaction of $200,551.50. Following the transaction, the executive vice president now directly owns 70,469 shares in the company, valued at $1,444,614.50. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, EVP Mitchell Waters sold 9,783 shares of the business’s stock in a transaction dated Tuesday, November 8th. The shares were sold at an average price of $20.50, for a total transaction of $200,551.50. Following the transaction, the executive vice president now directly owns 70,469 shares in the company, valued at $1,444,614.50. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CTO David A. Metcalfe sold 32,372 shares of the business’s stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $20.00, for a total transaction of $647,440.00. Following the transaction, the chief technology officer now owns 178,984 shares in the company, valued at $3,579,680. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 78,416 shares of company stock worth $1,580,010. 4.50% of the stock is owned by insiders.

NextGen Healthcare Profile

(Get Rating)

NextGen Healthcare, Inc provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions.

Further Reading

Institutional Ownership by Quarter for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.